Chemistry Wealth Management’s Analog Devices ADI Stock Holding History

Chemistry Wealth Management’s Portfolio ADI Stock Details ADI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Buy	+603	New	+$239K	0.04%	192

Other funds holding ADI

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Chemistry Wealth Management's ADI Position: Q2 2026 in Review

Chemistry Wealth Management opened a new position in Analog Devices (ADI) in Q2 2026: 603 shares worth $239K. The stake represents 0.04% of the portfolio and ranks #192 among its holdings.

1,045 funds tracked by Wall St. Rank hold ADI as of Q2 2026.

Chemistry Wealth Management held 603 shares of Analog Devices worth $239K as of Q2 2026.
Analog Devices was a new Chemistry Wealth Management position in Q2 2026.
Analog Devices made up 0.04% of Chemistry Wealth Management's portfolio in Q2 2026, its #192 holding.
1,045 funds tracked by Wall St. Rank held Analog Devices as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.